Article info

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Authors

  1. Correspondence to Dr Ioannis Patrikios; i.patrikios{at}euc.ac.cy; Dr Marios C Pantzaris; pantzari{at}cing.ac.cy
View Full Text

Citation

Pantzaris MC, Bakirtzis C, Grigoriadis N, et al
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Publication history

  • Received June 13, 2022
  • Accepted October 3, 2022
  • First published November 4, 2022.
Online issue publication 
October 18, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.